Mirador Capital Partners LP Cytokinetics Inc Transaction History

Mirador Capital Partners LP

$597 Million
Q2 2025

A detailed history of Mirador Capital Partners LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Mirador Capital Partners LP holds 144,347 shares of CYTK stock, worth $4.92 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

144,347

Previous 99,125 45.62%

Holding current value

$4.92 Million

Previous $4.28 Million 11.4%

% of portfolio

0.8%

Previous 0.8%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	BUY	$29.84 - $42.92 $1.35 Million - $1.94 Million	45,222 Added 45.62%	144,347 $4.77 Million
Q1 2025 Apr 08, 2025	BUY	$40.19 - $51.12 $1.35 Million - $1.71 Million	33,489 Added 51.02%	99,125 $4.28 Million
Q4 2024 Jan 14, 2025	BUY	$46.36 - $58.62 $46,823 - $59,206	1,010 Added 1.56%	65,636 $3.09 Million
Q3 2024 Oct 04, 2024	BUY	$51.22 - $60.16 $75,959 - $89,217	1,483 Added 2.35%	64,626 $3.41 Million
Q2 2024 Jul 12, 2024	BUY	$47.86 - $75.05 $1.33 Million - $2.08 Million	27,688 Added 78.09%	63,143 $3.42 Million
Q1 2024 Apr 17, 2024	SELL	$63.75 - $108.06 $860,433 - $1.46 Million	-13,497 Reduced 27.57%	35,455 $2.49 Million
Q4 2023 Jan 19, 2024	SELL	$26.88 - $83.49 $179,450 - $557,379	-6,676 Reduced 12.0%	48,952 $4.09 Million
Q3 2023 Oct 05, 2023	BUY	$29.46 - $36.61 $55,679 - $69,192	1,890 Added 3.52%	55,628 $1.64 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $92,836 - $115,974	-2,846 Reduced 5.03%	53,738 $1.75 Million
Q1 2023 Apr 14, 2023	SELL	$33.36 - $45.71 $71,657 - $98,185	-2,148 Reduced 3.66%	56,584 $1.99 Million
Q4 2022 Feb 09, 2023	SELL	$35.77 - $51.11 $2.5 Million - $3.57 Million	-69,753 Reduced 54.29%	58,732 $2.69 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $1.35 Million - $1.91 Million	-35,098 Reduced 21.46%	128,485 $6.23 Million
Q2 2022 Aug 05, 2022	BUY	$33.93 - $48.92 $138,604 - $199,838	4,085 Added 2.56%	163,583 $6.43 Million
Q1 2022 May 06, 2022	BUY	$29.74 - $46.0 $204,581 - $316,434	6,879 Added 4.51%	159,498 $5.87 Million
Q4 2021 Feb 02, 2022	SELL	$34.35 - $46.38 $372,937 - $503,547	-10,857 Reduced 6.64%	152,619 $6.96 Million
Q3 2021 Nov 09, 2021	BUY	$18.54 - $35.74 $92,273 - $177,877	4,977 Added 3.14%	163,476 $5.84 Million
Q2 2021 Jul 27, 2021	BUY	$19.79 - $26.99 $186,322 - $254,110	9,415 Added 6.32%	158,499 $3.14 Million
Q1 2021 Apr 29, 2021	SELL	$18.57 - $25.68 $61,485 - $85,026	-3,311 Reduced 2.17%	149,084 $3.47 Million
Q4 2020 Jan 20, 2021	BUY	$15.26 - $28.61 $614,535 - $1.15 Million	40,271 Added 35.92%	152,395 $3.17 Million
Q3 2020 Nov 12, 2020	BUY	$20.58 - $28.96 $329,629 - $463,852	16,017 Added 16.67%	112,124 $2.43 Million
Q2 2020 Aug 06, 2020	SELL	$11.15 - $24.64 $13,904 - $30,726	-1,247 Reduced 1.28%	96,107 $2.27 Million
Q1 2020 May 11, 2020	SELL	$8.75 - $16.3 $44,817 - $83,488	-5,122 Reduced 5.0%	97,354 $1.62 Million
Q4 2019 Jan 17, 2020	BUY	$7.95 - $11.84 $814,684 - $1.21 Million	102,476 New	102,476 $1.09 Million

Others Institutions Holding CYTK

# of Institutions

389

Shares Held

127M

Call Options Held

3.63M

Put Options Held

835K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.21B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Account

Mirador Capital Partners LP Cytokinetics Inc Transaction History